| Previous Close | 32.95 |
| Open | 32.91 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 32.65 - 32.97 |
| 52 Week Range | 29.83 - 35.38 |
| Volume | 15,490,145 |
| Avg. Volume | 18,464,160 |
| Market Cap | 194.97B |
| Beta | 1.05 |
| PE Ratio (TTM) | 27.50 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.92%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Motley Fool•12 hours ago
Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant
Besponsa's FDA approval for use in some leukemia patients continues to position the company as a leading player in cancer treatment.
- Motley Fool•13 hours ago
Here's How Much $10,000 Invested in Pfizer in 1977 Is Worth Now
Pfizer's last 40 years show what it takes to become a millionaire: Buy, hold, and reinvest.
- Barrons.com•2 days ago
[$$] Healthy Dividends
When it comes to health care, pharmaceutical companies get a lot of attention, because many offer attractive yields. Pfizer’s (PFE), for example, was 3.9% late last week, and Bristol Myers Squibb’s (BMY) was 2.7%.
